Analyze Your Search


  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Prostate Cancer
  Follow Topic   Edit Search
Your search returned 16 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
European urology 
... repair genes were recently reported in 8-12% of patients with metastatic castration-resistant prostate cancer (mCRPC... for therapies exploiting defective DNA repair using a liquid biopsy AbstractText: Patients with metastatic prostate cancer and germline DNA repair defects exhibit a poor response to standard hormonal therapies, but ... Keyword: Castration-resistant prostate cancer.
Oncology (4)
Prostatic Neoplasms (4), Neoplasms (3), more mentions
CitationSubset: AIM. CitationSubset: IM. DescriptorName: Decision Making. DescriptorName: Humans. DescriptorName: Male. DescriptorName: Patient Participation. DescriptorName: Patient Reported Outcome Measures. DescriptorName: Physicians. DescriptorName: Prostatic Neoplasms.
Oncology (1)
Prostatic Neoplasms (2), more mentions
AbstractText: Understanding the adverse effects of contemporary approaches to localized prostate cancer treatment could inform shared decision making AbstractText: To compare functional ... diagnosed in 2011-2012 with clinical stage cT1-2, localized prostate cancer, with prostate-specific antigen levels less than 50 ng/mL ... diagnosis AbstractText: Patient-reported function on the 26-item Expanded Prostate Cancer Index Composite (EPIC) 36 months after enrollment.
Oncology (6), Urology (3)
Prostatic Neoplasms (6), Urinary Incontinence (3), more mentions
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 
Abstract: Purpose Men with localized prostate cancer often are treated with external radiotherapy (RT) over 8 to ... We conducted a multicenter randomized noninferiority trial in intermediate-risk prostate cancer (T1 to 2a, Gleason score ≤ 6, and prostate-specific antigen ... local or distant failure, or death as a result of prostate cancer.
Oncology (6)
Prostatic Neoplasms (6), more mentions
AbstractText: Patients diagnosed with localized prostate cancer have to decide among treatment strategies that may differ in ... 1141 men (57% participation among eligible men) with newly diagnosed prostate cancer were enrolled from January 2011 through June 2013 in collaboration ... active surveillance AbstractText: Quality of life using the validated instrument Prostate Cancer Symptom Indices was assessed at baseline (pretreatment) and 3, 12 ...
Oncology (6), Urology (3), Men's Health (3)
Prostatic Neoplasms (5), Urinary Incontinence (3), Neoplasms (1), more mentions
Little is known about men with localized prostate cancer who seek second opinions, the reasons why, and the association ... care AbstractText: We surveyed men who were diagnosed with localized prostate cancer in the greater Philadelphia area from 2012 to 2014... models to evaluate the relationship between second opinions and definitive prostate cancer treatment and perceived quality of care AbstractText: A total of ...
Oncology (14)
Neoplasms (8), Prostatic Neoplasms (6), more mentions
European urology 
... RADS 4), or highly likely (PI-RADS 5) to be clinically significant (cs) prostate cancer (PCa) AbstractText: We retrospectively included 1057 patients having MRGB, between January 2012 and ... Prostate Imaging Reporting and Data System yields high detection rates of clinically significant prostate cancer Keyword: In-bore biopsy... Keyword: Prostate cancer.
Oncology (4)
Prostatic Neoplasms (4), more mentions
European urology 
Abstract: Metastasis-directed therapy is of interest for the management of oligometastatic prostate cancer. Improved imaging may help with patient selection, but the approach to metastatic prostate cancer of "catching 'em all", or "Pokemet", must be considered experimental..
Oncology (4)
Prostatic Neoplasms (3), more mentions
European urology 
... prescriptions are unknown AbstractText: To determine the long-term effects of different exercise modes on fatigue in prostate cancer patients undergoing ADT AbstractText: Between 2009 and 2012, 163 prostate cancer patients aged 43-90 y on ADT were randomised to exercise targeting the musculoskeletal system (impact loading ... Keyword: Prostate cancer.
Oncology (5)
Prostatic Neoplasms (4), Neoplasms (1), more mentions
JAMA oncology 
To ProtecT Our Patients With Prostate Cancer..
Oncology (2)
Prostatic Neoplasms (2), more mentions
International journal of radiation oncology, biology, physics 
Six Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer..
Oncology (2)
Prostatic Neoplasms (2), more mentions
Head and neck pathology 
... salivary gland carcinomas with high grade transformation, low grade cribriform cystadenocarcinoma, and squamous cell carcinomas involving parotid. Furthermore, the observation that SDC shares AR expression with prostate cancer and apocrine breast cancer foresaw the discovery of common molecular alterations between SDC and these tumor types and draw attention to androgen deprivation therapy for SDC patients Keyword: Androgen receptor. Keyword: Apocrine.
Oncology (2)
Carcinoma (4), Squamous Cell Carcinoma (1), Cystadenocarcinoma (1), more mentions
Annals of internal medicine 
Three recent recommendations provide examples of how the USPSTF has used these principles: the 2015 recommendation on screening for abnormal blood glucose and type 2 diabetes; the 2016 recommendation on screening for breast cancer; and the recommendation on screening for prostate cancer, which is currently in progress. A more comprehensive list of recommendations that includes considerations for specific populations is ...
Oncology (2), Endocrine Disorders (1)
Diabetes Mellitus, Type 2 (1), Prostatic Neoplasms (1), Breast Neoplasms (1), more mentions
JAMA neurology 
The PREADViSE trial was ancillary to the Selenium and Vitamin E Cancer Prevention Trial (SELECT), a randomized clinical trial of the same antioxidant supplements for preventing prostate cancer, which closed in 2009 owing to findings from a futility analysis. The PREADViSE trial recruited 7540 men, of whom 3786 continued into the cohort study.
Neuroscience (12), Oncology (2)
Dementia (10), Alzheimer Disease (2), Prostatic Neoplasms (1), more mentions
JAMA oncology 
To date, AR-targeted drugs have been approved only for treatment of prostate cancer; however, AR-targeted treatment for breast cancer is an area of active investigation. Through review of preclinical studies, retrospective clinical studies, and clinical trials, we examined the biology of AR and AR-related pathways, the potential for AR-targeted therapies in breast cancer, and potential biomarkers ...
Oncology (10)
Breast Neoplasms (9), Prostatic Neoplasms (1), more mentions
Nature communications 
... key-pathophysiological features of MPB and may represent promising targets for the development of novel therapeutic options. The data provide molecular evidence that rather than being an isolated trait, MPB shares a substantial biological basis with numerous other human phenotypes and may deserve evaluation as an early prognostic marker, for example, for prostate cancer, sudden cardiac arrest and neurodegenerative disorders.
Oncology (1), Men's Health (1)
Alopecia (2), Prostatic Neoplasms (1), Sudden Cardiac Arrest (1), more mentions